Capital Allergy Respiratory Disease Center

Sacramento, California 95819

0 studies enrolling now · 5 studies all time

What they study most

Atopic Dermatitis, COPD, Cystic Fibrosis, Primary Immunodeficiency Diseases (PID), Seasonal Allergic Rhinitis

Studies at this site

• Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global) — Completed
• A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease — Completed
• Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease — Completed
• A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR) — Completed
• Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification — Stopped early